July 2012 – Page 2 – Policy & Medicine

USPSTF Transparency and Accountability Act of 2012

The Food and Drug Administration Safety and Innovation Act (FDASIA): Summary of GDUFA, MDUFA, BsUFA and Pediatrics

FDA: Recently Signed PDUFA 5 Provisions to Address Drug Shortages

FDA: Food and Drug Administration Safety and Innovation Act (FDASIA) and Patient Focused Drug Development

Medical Progress is Not Easy: Complaining About it is Much Easier than Progress

Getting from Volume to Value in Healthcare

FDA Outlines Warning Letters for Promotion of Prescription Pharmaceuticals

Geisinger Health System and Merck Partnership to Improve Patient Health Outcomes

FDA Releases Final Risk Evaluation and Mitigation Strategies (REMS) for Extended Release/Long Acting Opioids Including a Prescriber Education Program

Massachusetts Passes Partial Repeal of The Pharmaceutical and Device Manufactures Code of Conduct – AKA “The Gift Ban”